MDA
NVS icon

Minot DeBlois Advisors’s Novartis NVS Stock Holding History

Minot DeBlois Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Sell
7,091
-465
-6% -$69.7K 0.95% 31
2026
Q1 		$1.15M Sell
7,556
-409
-5% -$62.7K 1.05% 31
2025
Q4 		$1.1M Sell
7,965
-398
-5% -$52.1K 0.99% 33
2025
Q3 		$1.07M Sell
8,363
-542
-6% -$66.1K 0.97% 30
2025
Q2 		$1.08M Sell
8,905
-995
-10% -$112K 1.02% 28
2025
Q1 		$1.1M Sell
9,900
-285
-3% -$30.3K 1.1% 26
2024
Q4 		$991K Buy
+10,185
New +$1.09M 0.91% 32

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Minot DeBlois Advisors's NVS Position: Q2 2026 in Review

Minot DeBlois Advisors reduced its Novartis (NVS) stake by 6.2% in Q2 2026, selling an estimated $69.7K and leaving 7,091 shares worth $1.11M. The position accounts for 0.95% of the portfolio, ranked #31.

Minot DeBlois Advisors first reported a position in NVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.15M in Q1 2026. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Minot DeBlois Advisors held 7,091 shares of Novartis worth $1.11M as of Q2 2026.
  • Minot DeBlois Advisors sold 465 Novartis shares in Q2 2026, an estimated $69.7K.
  • Novartis made up 0.95% of Minot DeBlois Advisors's portfolio in Q2 2026, its #31 holding.
  • Minot DeBlois Advisors first reported a position in Novartis in Q4 2024 and has held it in 7 quarters since.
  • Minot DeBlois Advisors's Novartis position peaked at $1.15M in Q1 2026.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Minot DeBlois Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.